Myo-Inositol vs Metformin for PCOS

For Healthcare Professionals Only

Metformin is one of the most prescribed medications for people with PCOS. While metformin can be effective for improving insulin resistance, it is not well tolerated by many women, which is why Myo-Inositol has become an increasingly popular (and research-supported) alternative.
Let’s look at how they compare.

How Does Metformin Work for PCOS?

Metformin works as an insulin sensitizer, meaning it helps lower blood glucose and insulin levels. It does this in three main ways:
•    Decreasing the liver’s production of glucose
•    Increasing insulin sensitivity in muscle, liver, and fat cells
•    Reducing carbohydrate absorption in the gut.

For some women with PCOS, this can lead to:

•    Lower insulin levels
•    More regular menstrual cycles
•    Improved ovulation and fertility

However, Metformin doesn’t work for everyone, and more importantly, many women can’t tolerate it.

The Biggest Problem with Metformin: GI Side Effects

Common side effects include: 
•    Nausea
•    Diarrhoea
•    Bloating
•    Abdominal cramping
•    Gas

For some women, these symptoms are mild. For others, they are severe enough to cause them to stop the medication entirely.

This is where Myo-inositol’s come in.

What is Myo-Inositol? Benefits and Mechanisms for PCOS

Myo-inositol is a naturally occurring compound that plays an essential role in insulin signalling and hormone regulation. It has been extensively studied in women with PCOS and is now widely used to support both metabolic and reproductive health.
Unlike metformin, which forces changes in glucose production and absorption, myo-inositol works by helping the body respond to insulin more efficiently, addressing insulin resistance at a cellular level.
Because of this, myo-inositol is often better tolerated and easier to use long term.

Myo-Inositol Works for PCOS Patients

How In women with PCOS, insulin resistance is often caused by faulty signalling inside the cell. Myo-inositol acts as a key messenger in the insulin signalling pathway, helping glucose move from the bloodstream into the cell where it can be used for energy.

When insulin signalling improves:
•    Less insulin is needed
•    Blood sugar levels stabilise
•    Ovarian hormone production becomes more balanced

This improved insulin response supports regular ovulation and menstrual cycles, making myo-inositol particularly effective for women with irregular periods or difficulty conceiving.

Why Myo-Inositol is Often Better Tolerated Than Metformin

One of the biggest differences between myo-inositol and metformin is side effects.
Metformin commonly causes gastrointestinal symptoms such as nausea, diarrhoea, bloating, and abdominal discomfort. These side effects are one of the main reasons women stop taking it.
Myo-inositol, on the other hand, has an excellent safety and tolerability profile. Clinical trials consistently show minimal to no gastrointestinal side effects, making it a more sustainable option for many women.

Myo-Inositol vs Metformin: Key Differences and Results

Multiple studies and meta-analyses show that myo-inositol and metformin are similarly effective for improving key PCOS outcomes, including:
•    Insulin resistance
•    Menstrual regularity
•    Hormonal balance
•    Ovulation

However, when side effects are compared, Myo consistently outperforms Metformin.

A 2023 meta-analysis of 26 randomised controlled trials found that Myo-Inositol produced 84% fewer side effects than metformin, while achieving similar improvements in metabolic and hormonal markers.

This makes Myo-Inositol a strong first-line option for many women with PCOS, especially those who prioritise tolerability.

Frequently Asked Questions

1. What is the difference between Myo-Inositol and Metformin for PCOS?

   Metformin works by reducing glucose production and improving insulin sensitivity, while Myo-Inositol supports insulin signalling at a cellular level, helping the body respond to insulin more efficiently.

2. Is Myo-Inositol as effective as Metformin for PCOS?

   Multiple studies and meta-analyses show that Myo-Inositol and Metformin are similarly effective for improving key PCOS outcomes, including insulin resistance, menstrual regularity, hormonal balance, and ovulation.

3. Why is Myo-Inositol often better tolerated than Metformin?

   Metformin is commonly associated with gastrointestinal side effects such as nausea, diarrhoea, bloating, abdominal cramping, and gas. Myo-Inositol has an excellent safety and tolerability profile, with clinical trials consistently showing minimal to no gastrointestinal side effects.

4. How can Myo-Inositol support ovulation and menstrual cycle regularity in PCOS?

   In women with PCOS, insulin resistance is often linked to faulty signalling inside the cell. Myo-Inositol acts as a key messenger in the insulin signalling pathway, supporting insulin response, which can help stabilise blood sugar levels, balance ovarian hormone production, and support regular ovulation and menstrual cycles.

 

References

Greff, D., Juhász, A.E., Váncsa, S., Váradi, A., Sipos, Z., Szinte, J., Park, S., Hegyi, P., Nyirády, P., Ács, N. & Horváth, E.M., 2023. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta‑analysis of randomized controlled trials. Reproductive Biology and Endocrinology, 21:10. Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials - PubMed

Facchinetti, F., Orrù, B., Grandi, G. & Unfer, V., 2019. Short‑term effects of metformin and myo‑inositol in women with polycystic ovarian syndrome (PCOS): a meta‑analysis of randomized clinical trials. Gynecological Endocrinology, 35(3), pp.198–206. https://doi.org/10.1080/09513590.2018.1540578 Effects of myo-inositol vs. metformin on hormonal and metabolic parameters in women with PCOS: a meta-analysis - PubMed

Fatima, K. et al., 2023. Effects of myo‑inositol vs metformin on hormonal and metabolic parameters in women with PCOS: a meta‑analysis. Annals of the Royal Academy of Medicine in Ireland, 2023. Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial | MDPI

Unfer, V., 2017. Myo‑inositol effects in women with PCOS: a meta‑analysis of randomized controlled trials. Endocrine Connections, 6(8). Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials in: Endocrine Connections Volume 6 Issue 8 (2017)

Ravn, P. et al., 2022. Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: randomized trial. Metabolites, 12(12), 1183. Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial | MDPI

Gudović, A. et al., 2024. The comparative effects of myo‑inositol and metformin therapy on the clinical and biochemical parameters of women of normal weight suffering from PCOS. Biomedicines, 12(2), 349. Comparison of Metformin and Myoinositol In Improving Insulin Sensitivity of Women with Polycystic Ovarian Syndrome | Pakistan Armed Forces Medical Journal